SCHEMBL10018871

SCHEMBL10018871

c1ccc(-c2cc(-c3ccc4c5ccccc5c5ccccc5c4c3)c3sc4c(-c5ccc6c7ccccc7c7ccccc7c6c5)cc(-c5ccccc5)cc4c3c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.36
LIMK1 P53667 3/20 0.35
MEN1 O00255 1/20 0.34
APAF1 O14727 1/20 0.34
NPC1 O15118 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
THRB P10828 1/20 0.34
XBP1 P17861 1/20 0.34
PTBP1 P26599 1/20 0.34
HTT P42858 1/20 0.34
RAB9A P51151 1/20 0.34
GALK1 P51570 1/20 0.34
BLM P54132 1/20 0.34
SMAD3 P84022 1/20 0.34
KMT2A Q03164 1/20 0.34
ATM Q13315 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15179387 0.98 LIMK1 (0.37) ALOX5LIMK1MEN1APAF1NPC1
SCHEMBL15179495 0.95 HSD17B1 (0.37) ALOX5LIMK1MEN1APAF1NPC1
SCHEMBL1687988 0.94 HSD17B1 (0.38) ALOX5LIMK1MEN1APAF1NPC1
SCHEMBL15179497 0.92 HSD17B1 (0.39) ALOX5LIMK1MEN1APAF1NPC1
SCHEMBL24433745 0.89 ALOX5 (0.43) ALOX5LIMK1MEN1APAF1NPC1
SCHEMBL21146672 0.89 ALOX5 (0.43) ALOX5LIMK1MEN1APAF1NPC1
SCHEMBL18975604 0.89 ALOX5 (0.43) ALOX5LIMK1MEN1APAF1NPC1
SCHEMBL15179507 0.89 LIMK1 (0.45) ALOX5LIMK1MEN1APAF1NPC1
SCHEMBL24606382 0.88 LIMK1 (0.44) ALOX5LIMK1MEN1APAF1NPC1
SCHEMBL10018874 0.87 KIF11 (0.37) NPC1MAPTRAB9AL3MBTL1TNKS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8743031-B2 Dibenzothiophene compound and organic light-emitting element based on the same CANON KABUSHIKI KAISHA (JP) 2014-06-03 US disclosed
US-8743031-B2 Dibenzothiophene compound and organic light-emitting element based on the same CANON KABUSHIKI KAISHA (JP) 2014-06-03 US disclosed
US-20120075171-A1 DIBENZOTHIOPHENE COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT BASED ON THE SAME CANON KABUSHIKI KAISHA (JP) 2012-03-29 US disclosed
US-20120075171-A1 DIBENZOTHIOPHENE COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT BASED ON THE SAME CANON KABUSHIKI KAISHA (JP) 2012-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120075171-A1 DIBENZOTHIOPHENE COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT BASED ON THE SAME TPT1, RFT1, ARNT ALOX5 2608/4885LIMK1 2383/4885MEN1 683/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.